NovoCure Ltd (NASDAQ: NVCR) stock closed at $17.78 on 10/15/24 after a major increase of 10.7%. Moreover, this advance was accompanied by exceptionally high trading volume at 281% of normal. The stock has risen 21.7% during the last week and has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, NVCR is expected to continue to be Value Creation neutral.
NovoCure has a current Value Trend Rating of D (Negative). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. NovoCure has a very low Appreciation Score of 10 but a slightly positive Power Rating of 66, with the Negative Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment